Back to search
FDAFDA · Food and drugs·Recall number Z-2088-2014

Hemochron Jr. Whole Blood Microcoagulation System APTT Cuvette. For in vitro diagnostic coagulation test. Catalog number J103.

Published July 30, 2014 · Recall initiated: June 20, 2014

Summary

FDA records medical device Class II recall Z-2088-2014, published July 30, 2014 and initiated June 20, 2014. Recalling firm: ITC-Nexus Dx; Status: Terminated; Reported quantity: US- 315 cuvettes; OUS - 2835 cuvettes; Lot: Lot Number A4JCA001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Test results may be erroneously elevated or report an out-of-range high (OOR-H) error code in non heparinized blood samples.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ITC-Nexus Dx
Distributor
Worldwide Distribution - US including the states of Georgia, Virginia and New York., and the countries of Canada, France, Italy, Liechtenstein and Romania.
Lot
Lot Number A4JCA001
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Hemochron Jr. Whole Blood Microcoagulation System APTT Cuvette. For in vitro diagnostic coagulation test. Catalog number J103. recalled?

Yes. FDA published recall Z-2088-2014 on July 30, 2014. Reported hazard: Test results may be erroneously elevated or report an out-of-range high (OOR-H) error code in non heparinized blood samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter